New York State Common Retirement Fund’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $544K | Buy |
107,475
+30,300
| +39% | +$153K | ﹤0.01% | 1879 |
|
|
2025
Q1 | $408K | Buy |
77,175
+13,800
| +22% | +$73K | ﹤0.01% | 1955 |
|
|
2024
Q4 | $428K | Hold |
63,375
| – | – | ﹤0.01% | 1995 |
|
|
2024
Q3 | $418K | Sell |
63,375
-21,500
| -25% | -$142K | ﹤0.01% | 2005 |
|
|
2024
Q2 | $637K | Buy |
84,875
+27,419
| +48% | +$206K | ﹤0.01% | 1947 |
|
|
2024
Q1 | $573K | Sell |
57,456
-958
| -2% | -$9.55K | ﹤0.01% | 2023 |
|
|
2023
Q4 | $576K | Buy |
58,414
+10,177
| +21% | +$100K | ﹤0.01% | 2041 |
|
|
2023
Q3 | $369K | Buy |
48,237
+5,879
| +14% | +$45K | ﹤0.01% | 2174 |
|
|
2023
Q2 | $316K | Sell |
42,358
-28,732
| -40% | -$214K | ﹤0.01% | 2305 |
|
|
2023
Q1 | $474K | Sell |
71,090
-23,882
| -25% | -$159K | ﹤0.01% | 2203 |
|
|
2022
Q4 | $732K | Sell |
94,972
-5
| -0% | -$39 | ﹤0.01% | 2127 |
|
|
2022
Q3 | $1.01M | Buy |
94,977
+345
| +0.4% | +$3.67K | ﹤0.01% | 1964 |
|
|
2022
Q2 | $770K | Buy |
94,632
+14,212
| +18% | +$116K | ﹤0.01% | 2158 |
|
|
2022
Q1 | $576K | Buy |
80,420
+12,903
| +19% | +$92.4K | ﹤0.01% | 2350 |
|
|
2021
Q4 | $1.16M | Buy |
67,517
+53,114
| +369% | +$910K | ﹤0.01% | 2053 |
|
|
2021
Q3 | $331K | Sell |
14,403
-3,697
| -20% | -$85K | ﹤0.01% | 2682 |
|
|
2021
Q2 | $661K | Buy |
+18,100
| New | +$661K | ﹤0.01% | 2445 |
|